School of Medicine


Showing 21-30 of 31 Results

  • Albert Rogers

    Albert Rogers

    Instructor, Medicine - Cardiovascular Medicine

    BioDr. Albert (A.J.) Rogers is a Clinical Cardiac Electrophysiologist and research scientist at Stanford University. His undergraduate coursework in Biomedical Engineering at Duke University focused on neurobiology, signal processing, and computer modeling while his research investigated piezoelectric arrays for intracardiac ultrasound and computer vision of 3D ultrasound images for automated surgical robot tasks (Stephen Smith Laboratory). He earned his medical and business degrees (MD/MBA) from the University of North Carolina School of Medicine and the Kenan-Flagler Business School at UNC (focus in Healthcare Entrepreneurship). He has medical technology experience ranging from basic and translational research to first-in-man studies, device development, and entrepreneurship. He completed training in Internal Medicine, Cardiovascular Medicine, and Clinical Cardiac Electrophysiology at Stanford University. His research endeavors to explore mechanisms of cardiac fibrillation using techniques of signal processing, machine learning, and in silico modeling. Outside of his research and clinical pursuits, A.J. enjoys athletics of all kinds (especially soccer and sand volleyball), travelling, and cooking.

  • Angela Rogers

    Angela Rogers

    Associate Professor of Medicine (Pulmonary and Critical Care)

    Current Research and Scholarly InterestsWe use genetics and genomics methodologies to identify novel ARDS pathobiology; we hope that this will enable identification of novel biomarkers, phenotypes, and treatments for the disease. We are building a plasma biobank of critically ill patients at Stanford, with a particular focus on metabolic changes in critical illness.

  • Rajat Rohatgi

    Rajat Rohatgi

    Associate Professor of Biochemistry and of Medicine (Oncology)

    Current Research and Scholarly Intereststhe overall goal of my laboratory is to uncover new regulatory mechanisms in signaling systems, to understand how these mechanisms are damaged in disease states, and to devise new strategies to repair their function.

  • Allyson Rosen, Ph.D.

    Allyson Rosen, Ph.D.

    Clinical Associate Professor (Affiliated), Psych/Public Mental Health & Population Sciences
    Staff, Psychiatry and Behavioral Sciences

    BioRESEARCH FOCUS
    Translational cognitive neuroscience of aging and dementia. Neuroethics.

    TRAINING
    Dr. Rosen is board certified in clinical neuropsychology with a geriatric focus. She completed college at Brown University, a clinical psychology Ph.D. from Case Western Reserve University, clinical neuropsychology internship at the Long Island Jewish Hospital in New York, and clinical neuropsychology postdoctoral fellowship at the Medical College of Wisconsin. Dr. Rosen completed specialty research fellowship training at the National Institute on Aging (Intramural Research Training Award) and Stanford (NRSA F32, K01) in functional imaging and noninvasive brain stimulation with support from NIA.

    CLINICAL AND RESEARCH ACTIVITIES
    Dr. Rosen is Director of Dementia Education at the Mental Illness Research Education and Clinical Center at the Palo Alto VAHCS. She is also a neuropsychologist and part of the consensus clinical group and education core at the Stanford’s Alzheimer’s Disease Research Center (NIA). Dr. Rosen’s funded research has focused on applying cognitive neuroscience of aging to improve clinical practice in older adults by using cognitive measures, brain imaging, and noninvasive brain stimulation such as TMS. Studies include using fMRI as an outcome measure for cognitive training, studying how to improve the accuracy of transcranial magnetic stimulation targeting with and without image guidance, and using structural MRI to avoid postoperative cognitive decline and improve outcome from carotid vascular procedures. She has a longstanding commitment to neuroethics and leads a feature in the Journal of Alzheimer Disease that focuses on ethical issues in new and emerging AD applications.

    ETHICS EDITOR, JOURNAL OF ALZHEIMER'S DISEASE
    Ethics Review
    http://www.j-alz.com/blogs/discussion/protecting-progress

    MIRECC DEMENTIA EDUCATION
    http://www.mirecc.va.gov/visn21/education/dementia_education.asp

  • Glenn Rosen

    Glenn Rosen

    Associate Professor of Medicine (Pulmonary and Critical Care Medicine), Emeritus

    Current Research and Scholarly InterestsOur laboratory examines apoptotic and cell signaling pathways in cancer and lung disease. We are studying signaling pathways that regulate oxidative stress responses and cancer cell growth. Part of these studies focus on analysis of non-canonical transcription regulatory functions of the TERC and Tert components of telomerase in lung disease and cancer.

  • David Rosenthal

    David Rosenthal

    Professor of Pediatrics (Pediatric Cardiology)

    Current Research and Scholarly InterestsResearch interests include the study of Heart Failure, Cardiomyopathy and ventricular dysfunction in children, from a clinical perspective. Investigations include clinical trials of medications, cardiac resynchronization, and mechanical circulatory support.

  • Elsie Gyang Ross

    Elsie Gyang Ross

    Assistant Professor of Surgery (Vascular Surgery) and of Medicine (BMIR)

    BioDr. Ross is a vascular surgeon and research scientist. She graduated from Stanford University School of Medicine in 2011 and completed her vascular surgery 0+5 residency at Stanford University School of Medicine in 2018. During her residency, she completed a two-year post-doctoral fellowship in biomedical informatics. Her current research focuses on using machine learning and electronic health records for early disease identification, precision medicine, and evaluating opportunities to engage in patient education beyond the clinic.

  • Stephen J. Roth

    Stephen J. Roth

    Professor of Pediatrics (Cardiology)

    Current Research and Scholarly InterestsRandomized Therapeutic Trials in Pediatric Heart Disease, NIH/U01 GrantNo. HL68285 2001-2006.
    Heparin and the Reduction of Thrombosis (HART) Study. Pediatric Health Research Fund Award, Stanford Univ Sch of Medicine, 2005-2006.
    A Pilot Trial fo B-type Natriuretic Peptide for Promotion of Urine Output in Diuretic-Resistant Infants Following Cardiovascular Surgery.Pediatric Health Research Fund Award, Stanford Univ Sch of Medicine, 2005-2006.